NCPA's qAM

qAM

Contact your senator today to urge a DIR fix

by NCPA | Jun 11, 2019

The Senate Finance Committee is expected to consider legislation addressing drug pricing as soon as June 19. NCPA has had several meetings with the committee urging it to address pharmacy DIR fees in this legislation in light of the Trump administration’s failure to act. Time is short, and the committee needs to hear that there is broader support in the Senate to address pharmacy DIR fees. Email your senators and encourage them to voice their support for such action and ensure it is included in the final legislative package.